Effects of repetitive transcranial magnetic stimulation on synaptic plasticity and apoptosis in vascular dementia rats

Behavioural Brain Research

Volumn 281, Issue , 2015, Pages 149-155

  Yang, Hui Yun ^a   Liu, Yang ^a   Xie, Jia Cun ^a   Liu, Nan Nan ^a   Tian, Xin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Long term potentiation; Morris water maze; Repetitive transcranial magnetic stimulation; Vascular dementia

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN BAX; PROTEIN BCL 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NMDA RECEPTOR A1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; LATENT PERIOD; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MEMORY; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOTOR PERFORMANCE; MULTIINFARCT DEMENTIA; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RAT; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SPATIAL LEARNING; STRUCTURE ANALYSIS; TRANSCRANIAL MAGNETIC STIMULATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; DEMENTIA, VASCULAR; DISEASE MODEL; HIPPOCAMPUS; MAZE TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PYRAMIDAL NERVE CELL; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BEHAVIOR, ANIMAL; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MAZE LEARNING; MEMORY; NEURONAL PLASTICITY; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84920156384     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.12.037     Document Type: Article

References (50)

1. Iadecola C. The pathobiology of vascular dementia. Neuron 2013, 80:844-866.
2. Levine D.A., Langa K.M. Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics 2011, 8:361-373.
3. Vaux D.L., Korsmeyer S.J. Cell death in development. Cell 1999, 96:245-254.
4. Waldmeier P.C. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:303-321.
5. Tang J.L., Gao W.J., Li J., Qian T., Zhang H.B., Liu S.S. The molecular and electrophysiological mechanism of buyanghuanwu decoction in learning and memory ability of vascular dementia rats. Brain Res Bull 2013, 99:13-18.
6. Xu X., Li Z., Yang Z., Zhang T. Decrease of synaptic plasticity associated with alteration of information flow in a rat model of vascular dementia. Neuroscience 2012, 206:136-143.
7. Zhang J., Li Y., Xu J., Yang Z. The role of N-methyl-d-aspartate receptor in Alzheimer's disease. J Neurol Sci 2014, 339:123-129.
8. Malenka R.C., Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21.
9. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
10. Castrén E., Oliga Y., Berzaghi M.P., Taimagaorgis G., Thoeuen H., Lindholm D. Bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain. Neuroscience 1994, 61:165-177.
11. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619.
12. Kumasaka D.K., Galvan V., Head E., Rohn T.T. Caspase cleavage of the amyloid precursor protein is prevented after overexpression of bcl-2 in a triple transgenic mouse model of Alzheimer's disease. Int J Physiol Pathophysiol Pharmacol 2009, 1:48-56.
13. Zhang L., Zhao H., Zhang X., Chen L., Zhao X., Bai X., et al. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Res Bull 2013, 96:45-53.
14. Cheng X.L., Li M.K. Effect of topiramate on apoptosis-related protein expression of hippocampus in model rats with Alzheimers disease. Eur Rev Med Pharmacol Sci 2014, 18:761-768.
15. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons. J Neurosci 1996, 16:7533-7539.
16. Wang T., Liu C.Z., Yu J.C., Jiang W., Han J.X. Acupuncture protected cerebral multi-infarction rats from memory impairment by regulating the expression of apoptosis related genes Bcl-2 and Bax in hippocampus. Physiol Behav 2009, 96:155-161.
17. Sun Z.K., Ma X.R., Jia Y.J., Liu Y.R., Zhang J.W., Zhang B.A. Effects of resveratrol on apoptosis in a rat model of vascular dementia. Exp Ther Med 2014, 7:843-848.
18. Guerra A., Assenza F., Bressi F., Scrascia F., Del Duca M., Ursini F., et al. Transcranial magnetic stimulation studies in Alzheimer's disease. Int J Alzheimers Dis 2011, 263817.
19. Gross M., Nakamura L., Pascual-Leone A., Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand 2007, 116:165-173.
20. Wu A.D., Fregni F., Simon D.K., Deblieck C., Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics 2008, 5:345-361.
21. Lee J.Y., Kim S.H., Ko A.R., Lee J.S., Yu J.H., Seo J.H., et al. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease. Brain Res 2013, 1537:290-302.
22. Wang F., Geng X., Tao H.Y., Cheng Y. The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area. J Mol Neurosci 2010, 41:145-155.
23. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the safety of repetitive transcranial magnetic stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998, 108:1-16.
24. Kotova O.V., Vorob'eva O.V. Evoked motor response thresholds during transcranial magnetic stimulation in patients with symptomatic partial epilepsy. Neurosci Behav Physiol 2007, 37:849-852.
25. Siebner H.R., Lang N., Rizzo V., Nitsche M.A., Paulus W., Lemon R.N., et al. Preconditioning of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: evidence for homeostatic plasticity in the human motor cortex. Neuroscience 2004, 24:3379-3385.
26. Vernieri F., Altamura C., Palazzo P., Altavilla R., Fabrizio E., Fini R., et al. 1-Hz repetitive transcranial magnetic stimulation increases cerebral vasomotor reactivity: a possible autonomic nervous system modulation. Brain Stimul 2014, 7:281-286.
27. Muller P.A., Dhamne S.C., Vahabzadeh-Hagh A.M., Pascual-Leone A., Jensen F.E., Rotenberg A. Suppression of motor cortical excitability in anesthetized rats by low frequency repetitive transcranial magnetic stimulation. PLOS ONE 2014, 9:e91065.
28. Tan T., Xie J., Liu T., Chen X., Zheng X., Tong Z., et al. Low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Aβ(1-42)-mediated memory deficits in rats. Exp Gerontol 2013, 48:786-794.
29. Ma J., Zhang Z., Kang L., Geng D., Wang Y., Wang M., et al. Repetitive transcranial magnetic stimulation (rTMS) influences spatial cognition and modulates hippocampal structural synaptic plasticity in aging mice. Exp Gerontol 2014, 58:256-268.
30. Nagakannan P., Shivasharan B.D., Thippeswamy B.S., Veerapur V.P. Effect of tramadol on behavioral alterations and lipid peroxidation after transient forebrain ischemia in rats. Toxicol Mech Methods 2012, 22:674-678.
31. Doeppner T.R., Hermann D.M. Stem cell-based treatments against stroke: observations from human roof-of-concept studies and considerations regarding clinical applicability. Front Cell Neurosci 2014, 29:1-8.
32. Gersner R., Kravetz E., Feil J., Pell G., Zangen A. Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals. J Neurosci 2011, 31:7521-7526.
33. Yang H., Qiao H., Tian X. Proteomic analysis of cerebral synaptosomes isolated from rat model of alzheimer's disease. Indian J Exp Biol 2011, 49:118-124.
34. Gruart A., Muñoz M.D., Delgado-García J.M. Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J Neurosci 2006, 26:1077-1087.
35. Brandeis R., Brandys Y., Yehuda S. The use of the Morris water maze in the study of memory and learning. Int J Neurosci 1989, 48:29-69.
36. McClean P.L., Hölscher C. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease. Neuropharmacology 2014, 76(Pt A):57-67.
37. Xu S., Liu G., Bao X., Wu J., Li S., Zheng B., et al. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number. J Alzheimers Dis 2014, 39:239-251.
38. McHugh T.J., Blum K.I., Tsien J.Z., Tonegawa S., Wilson M.A. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 1996, 87:1339-1349.
39. Man H.Y., Wang Q., Lu W.Y., Ju W., Ahmadian G., Liu L., et al. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron 2003, 38:611-624.
40. Calon F., Lim G.P., Morihara T., Yang F., Ubeda O., Salem N., et al. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 2005, 22:617-626.
41. Tsang S.W., Vinters H.V., Cummings J.L., Wong P.T., Chen C.P., Lai M.K. Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease. Neurobiol Aging 2008, 29:1524-1532.
42. Guerra A., Petrichella S., Vollero L., Ponzo D., Pasqualetti P., Määttä S., et al. Neurophysiological features of motor cortex excitability and plasticity in subcortical ischemic vascular dementia: a TMS mapping study. Clin Neurophysiol 2014, 10.1016/j.clinph.2014.07.036.
43. Nardone R., Bergmann J., Tezzon F., Ladurner G., Golaszewski S. Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study. J Neural Transm 2008, 115:737-743.
44. Pennisi G., Ferri R., Alagona G., Pennisi M., Malaguarnera G., Motta M., et al. Motor cortex hyperexcitability in subcortical ischemic vascular dementia. Arch Gerontol Geriatr 2011, 53:e111-e113.
45. Lee L., Siebner H.R., Rowe J.B., Rizzo V., Rothwell J.C., Frackowiak R.S., et al. Acute remapping within the motor system induced by low-frequency repetitive transcranial magnetic stimulation. J Neurosci 2003, 23:5308-5318.
46. Tatton W.G., Chalmers-Redman R.M., Ju W.Y., Wadia J., Tatton N.A. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm Suppl 1997, 49:245-268.
47. Ji H.J., Hu J.F., Wang Y.H., Chen X.Y., Zhou R., Chen N.H. Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus. Eur J Pharmacol 2010, 636:96-101.
48. Yoon K.J., Lee Y.T., Han T.R. Mechanism of functional recovery after repetitive transcranial magnetic stimulation (rTMS) in the subacute cerebral ischemic rat model: neural plasticity or anti-apoptosis?. Exp Brain Res 2011, 214:549-556.
49. Gao F., Wang S., Guo Y., Wang J., Lou M., Wu J., et al. Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischaemia: a microPET study. Eur J Nucl Med Mol Imaging 2010, 37:954-961.
50. Prakasa Babu P., Yoshida Y., Su M., Segura M., Kawamura S., Yasui N. Immunohistochemical expression of Bcl-2, Bax and cytochrome c following focal cerebral ischemia and effect of hypothermia in rat. Neurosci Lett 2000, 291:196-200.